These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7990448)

  • 21. Interference of herbal drinks with urinalysis for drugs of abuse.
    Winek CL; Elzein EO; Wahba WW; Feldman JA
    J Anal Toxicol; 1993; 17(4):246-7. PubMed ID: 8371557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of drugs in human hair using Abbott ADx, with confirmation by gas chromatography/mass spectrometry (GC/MS).
    Kintz P; Ludes B; Mangin P
    J Forensic Sci; 1992 Jan; 37(1):328-31. PubMed ID: 1545208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the REMEDi drug profiling system.
    Demedts P; Wauters A; Franck F; Neels H
    Eur J Clin Chem Clin Biochem; 1994 May; 32(5):409-17. PubMed ID: 8086525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC; ElSohly MA; Dubrovsky T; Twarowska B; Towt J; Salamone SJ
    J Anal Toxicol; 1998 Oct; 22(6):474-80. PubMed ID: 9788522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of opiates in urine: interpretation of comparison between the EIA and FPIA and confirmation of data with GC/MS].
    Giusiani M; Viviani P
    Minerva Med; 2001 Jun; 92(3):155-60. PubMed ID: 11404724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
    Caplan YH; Levine B
    J Anal Toxicol; 1989; 13(5):289-92. PubMed ID: 2693834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of drugs of abuse in urine of drivers involved in road accidents in France: a collaborative study.
    Marquet P; Delpla PA; Kerguelen S; Bremond J; Facy F; Garnier M; Guery B; Lhermitte M; Mathé D; Pelissier AL; Renaudeau C; Vest P; Seguela JP
    J Forensic Sci; 1998 Jul; 43(4):806-11. PubMed ID: 9670503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine.
    Wennig R; Moeller MR; Haguenoer JM; Marocchi A; Zoppi F; Smith BL; de la Torre R; Carstensen CA; Goerlach-Graw A; Schaeffler J; Leinberger R
    J Anal Toxicol; 1998; 22(2):148-55. PubMed ID: 9547412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of urine and hair testing for drugs of abuse in the control of abstinence in driver's license re-granting.
    Dufaux B; Agius R; Nadulski T; Kahl HG
    Drug Test Anal; 2012 Jun; 4(6):415-9. PubMed ID: 22447399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of five on-site immunoassay drugs-of-abuse testing devices.
    Taylor EH; Oertli EH; Wolfgang JW; Mueller E
    J Anal Toxicol; 1999; 23(2):119-24. PubMed ID: 10192416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adulterants causing false negatives in illicit drug testing.
    Mikkelsen SL; Ash KO
    Clin Chem; 1988 Nov; 34(11):2333-6. PubMed ID: 3052928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of enzyme immunoassay and gas chromatography/mass spectrometry in forensic toxicology.
    Fenton J; Schaffer M; Chen NW; Bermes EW
    J Forensic Sci; 1980 Apr; 25(2):314-9. PubMed ID: 6993619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.